Gri Labs

What Gri Labs does

GRI Labs is a privately held clinical diagnostic laboratory founded in 2016 and headquartered in Las Vegas, Nevada. The company operates a menu of hundreds of medical diagnostic tests centered on real-time PCR molecular testing — including respiratory pathogen panels (RTM-B/RTM-C), UTI/urinary tract microbiota panels, STD panels, wound care, gastrointestinal pathogen panels, and Covid-19 diagnostics — supplemented by LC-MS/MS-based toxicology, PCR-based pharmacogenomics (PGx), and standard serology and blood chemistry panels (CBC, BMP, CMP, lipid, thyroid, etc.). Its core technology stack combines PCR amplification with antimicrobial resistance markers, LC-MS/MS confirmation, and a cloud-based LIMS that integrates with provider EHR systems, including PointClickCare for skilled nursing and senior care facilities.

The company sells primarily to healthcare providers, skilled nursing and assisted living facilities, and Clinical Research Organizations (CROs) across the US Southwest — Nevada, California, Arizona, Utah, Texas and additional states — with free pickup in the greater Las Vegas area and courier logistics nationally. Revenue is generated per test order through fees billed to providers, facilities, and insurance reimbursement under Medicare, Medicaid, Medi-Cal, and participating private plans. On-site phlebotomy, custom client portals, color-coded patient reporting, and CRO-tailored protocol compliance are positioned as service differentiators against national reference labs.

GRI Labs is led by CEO Robert Cathey (25+ years of healthcare administration), with Dr. Andrew Gould (PhD, Molecular Pharmacology and Toxicology) overseeing laboratory services and Dr. Ronald Slaughter serving as Medical Director. The company holds CLIA certification, COLA accreditation, California and Nevada state HHS certifications, CMS certification, and California Covid Task Force authorization, and maintains partnerships with Community of Nevada Diagnostics (mobile imaging) and PointClickCare (EHR integration). No funding rounds, revenue figures, or external investors are disclosed in the available materials.

Name

Gri Labs

Legal name

GRI Labs

Website

https://grilabs.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

GRI Labs is a Las Vegas-based clinical diagnostic laboratory providing PCR molecular testing, toxicology, pharmacogenomics, and blood panel services to healthcare providers, skilled nursing facilities, and CROs across the US Southwest.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAGADAF

Molecular & Genetic Testing (PCR/NGS/qPCR)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical Services

SECONDARYHLAFAMAJ

Reference & Esoteric Testing Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAFAMAL

Clinical Research & Trial Central Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

Keywords

• Clinical diagnostic testing
• Molecular PCR testing
• Toxicology screening
• Pharmacogenomics testing
• Infectious disease panels

Headquarters

HQ city

Las Vegas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Diagnostic Laboratory Testing: Provides hundreds of medical diagnostic laboratory tests including serology, toxicology, and molecular PCR testing to healthcare providers, skilled nursing facilities, assisted living facilities, and research organizations. Revenue generated through test fees billed to healthcare providers, facilities, and insurance companies.
2. Insurance Reimbursement: Accepts Medicare, Medicaid, Medi-Cal, and various private insurance plans. Revenue flows through insurance reimbursement for covered diagnostic tests.
3. CRO Clinical Trial Testing: Partnership with Clinical Research Organizations providing flexible, compliant testing solutions tailored to study protocols and timelines for clinical trials.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

GRI Labs is a clinical diagnostic laboratory that performs PCR molecular testing (respiratory, urinary tract, STD, GI, wound care, COVID-19), LC-MS/MS toxicology screening, pharmacogenomics (PGx) testing, and a broad menu of blood/serology panels for healthcare providers, skilled nursing and assisted living facilities, and clinical research organizations. The lab is based in Las Vegas and serves clients across Nevada, California, Arizona, Utah, and Texas with on-site phlebotomy, courier logistics, and EHR-integrated reporting.

Product overview

GRI Labs is a medical diagnostic laboratory offering a comprehensive menu of hundreds of clinical diagnostic tests centered on real-time PCR molecular testing technology, supplemented by serology, toxicology, and pharmacogenomics services. The core offering consists of a unified testing platform with multiple specialized test panels including Respiratory Pathogen Testing (RTM-B/RTM-C), Covid-19 Diagnostic Testing, UTI/Urinary Tract Microbiota Testing, STD/Vaginal Tract Microbiota Panels, Integrated Women's Health Testing, Blood Testing Services (CBC, BMP, CMP, lipid, thyroid panels), Toxicology Testing via LC-MS/MS, PGx Drug-Gene Testing, Wound Care Testing, and Gastrointestinal Infections Testing. These products are offered as distinct diagnostic services to healthcare providers, skilled nursing/assisted living facilities, research organizations, and Clinical Research Organizations (CROs), with supporting services including on-site phlebotomy, EHR/LIMS integration, and color-coded patient-friendly reporting. The laboratory operates from Las Vegas serving California, Arizona, Nevada, Utah, Texas and other states.

Differentiator

Problem solved

Functional benefit

Products and services

• Respiratory Pathogen Testing (RTM-B and RTM-C) PCR-based respiratory tract microbiota (RTM) panels that detect common and uncommon respiratory pathogens including Covid-19, Influenza A/B, RSV, and Pneumonia from a single nasal or nasopharyngeal swab. Available as a Basic (RTM-B) or Comprehensive (RTM-C) panel detecting up to 33 bacterial and viral respiratory pathogens. Sold to healthcare providers, skilled nursing facilities, and assisted living facilities for patient and resident respiratory infection diagnosis.
• Covid-19 Diagnostic Testing Real-time PCR diagnostic test for detecting active SARS-CoV-2 (Covid-19) infection using respiratory samples, including nasopharyngeal swabs, nasal swabs, and lower respiratory secretions. Performed for healthcare providers, skilled nursing and assisted living facilities, and California Covid Task Force-authorized testing.
• UTI Test Using PCR Technology Real-time PCR-based urinary tract infection (UTI) test that detects 26 bacterial and fungal urinary tract microbiota pathogens including E. coli, Klebsiella, Enterococcus, and Candida species, with results delivered in under five hours and over 25% greater accuracy than traditional culture-based methods. Used by physician practices, skilled nursing facilities, and assisted living facilities for rapid UTI diagnosis.
• STD Panel Using PCR Technology Real-time PCR-based sexually transmitted disease panel detecting up to 34 pathogens including bacteria (Chlamydia, Gonorrhea, Treponema pallidum/syphilis), fungi (Candida species), protozoa (Trichomonas vaginalis), and viruses (HSV1, HSV2) via urine or vaginal swab. Sold to physician practices and women's health providers for comprehensive STD screening.
• Integrated Women's Health Testing Comprehensive women's health testing suite combining PCR-based UTI testing (up to 26 pathogens), vaginal tract microbiota testing (up to 34 pathogens), STD detection, toxicology screening (16 illicit drugs plus confirmation for 80 toxins), and blood testing services (metabolic panels, CBC, lipid, thyroid). Performed from urine, swab, and blood samples. Targeted at physician practices, OB/GYNs, and women's health programs.
• Blood Testing Services Extensive serology and blood panel testing including Complete Blood Count (CBC), Basic and Comprehensive Metabolic Panels (BMP/CMP), Lipid Panel, Thyroid Panel, Hepatic Panel, Renal Panel, Iron Studies, and individual tests such as SARS-CoV-2 Antibody, HbA1C, PSA, and Vitamin D. Used by physician practices and long-term care facilities for routine health monitoring and chronic disease management.
• Toxicology Testing Urine and saliva-based toxicology testing using LC-MS/MS technology for screening and confirmation of prescription and illicit drugs. Screens for 16+ illicit drugs with confirmation of up to 80+ drugs and toxins. Supports addiction treatment programs, workplace drug testing, pain management programs, and behavioral health settings with drug safety tests and compliance monitoring.
• PGx Drug-Gene Testing Pharmacogenomics (PGx) testing using PCR technology to analyze DNA from saliva samples, predicting drug efficacy and tolerance based on individual gene profiles including CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, SLCO1B1, and VKORC1. Used by pain management, behavioral health, and primary care providers to guide medication selection.
• Wound Care Testing PCR-based wound care testing that detects bacterial, viral, and fungal pathogens found in infected wounds and soft skin infections, with antibiotic resistance markers for multiple antibiotic classes including aminoglycoside, beta-lactam, macrolide, quinolone, and sulfonamide. Sold to skilled nursing facilities, assisted living facilities, and wound care clinics.
• Gastrointestinal (GI) Infections Testing PCR-based gastrointestinal pathogen panel detecting C. difficile, Norovirus, Rotavirus, Campylobacter, Cryptosporidium, E. coli variants, Giardia, Listeria, Salmonella, Shigella, Vibrio, and other GI pathogens. Used by physician practices, skilled nursing facilities, and assisted living facilities for infection control and outbreak investigation.
• On-Site Phlebotomy Services On-site phlebotomy and specimen collection services provided to facilities requiring support with blood draws and sample handling, available as a service offering alongside GRI's diagnostic testing menu. Primarily serves skilled nursing facilities, assisted living facilities, and physician offices that need convenient specimen collection on premises.

Quantifiable outcome

• Over 25% more accurate than traditional culture-based UTI detection methods
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature8 records

Partnerships

Three partnerships are on record, tiered core.

• Community of Nevada DiagnosticscoreStrategic or Co-development PartnerGRI Labs partners with Community of Nevada Diagnostics to provide hospital-quality digital X-ray and ultrasound services to skilled nursing facilities, assisted living facilities, and private residences. Their technologists and specially equipped vans bring state-of-the-art digital equipment directly to patient bedsides. Board-certified radiologists interpret results promptly.
• PointClickCarecoreTechnology or IntegrationPointClickCare integration enables GRI Labs to seamlessly connect with Electronic Health Record systems used by skilled nursing and senior care facilities. This partnership supports efficient ordering, tracking, and reporting of laboratory results.
• Clinical Research Organizations (CROs)coreStrategic or Co-development PartnerGRI Labs partners with Clinical Research Organizations to provide flexible, compliant testing solutions tailored to study protocols and timelines. The partnership enables CROs to advance studies efficiently with dependable molecular testing capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• NeoGenomics Laboratories: Specialty molecular and genetic testing lab with focus on oncology and infectious disease molecular diagnostics. Comparable in molecular technology stack though more oncology-weighted than GRI's infectious disease focus.
• Natera: Molecular diagnostics company focused on cell-free DNA and genetic testing. Comparable in molecular technology platform though concentrated in reproductive health and oncology rather than infectious disease PCR panels.
• Myriad Genetics: Molecular and genetic testing lab offering pharmacogenomic and specialty diagnostics. Direct overlap with GRI's PGx testing line and similar molecular technology base.

Broad incumbents

• Sonic Healthcare USA: Operates a network of regional clinical laboratories across multiple US states offering routine and molecular diagnostics. Comparable regional clinical lab footprint with similar provider and facility customer mix.
• Laboratory Corporation of America (LabCorp): National clinical laboratory with comprehensive PCR, serology, toxicology, and women's health testing. Competes with GRI on menu breadth, payor participation, and integrated EHR solutions across physician and SNF accounts.
• Quest Diagnostics: Largest US clinical reference lab offering the full menu GRI provides (molecular, toxicology, blood, women's health) plus national logistics and broad payor in-network status. Direct competitive threat on every test category where GRI competes.
• Eurofins Scientific: Global testing services group with clinical diagnostics operations in the US providing molecular and esoteric testing. Overlaps with GRI's PCR infectious disease and specialty testing menu through its clinical diagnostics division.
• BioReference Laboratories (OPKO Health): Full-service clinical reference lab offering molecular, women's health, and specialty diagnostics with national reach. Comparable in menu and customer profile; competes for physician office and SNF accounts in overlapping geographies.

Direct peers

• HealthTrackRx: Specialty molecular diagnostics lab focused on PCR-based infectious disease testing for urinary, respiratory, and wound care pathogens. Closely matches GRI's PCR-centric menu and serves a similar outpatient provider and facility customer base.
• Aegis Sciences Corporation: Clinical laboratory specializing in toxicology via LC-MS/MS alongside infectious disease and pharmacogenomic testing. Overlaps directly with GRI's LC-MS/MS toxicology, PGx, and PCR testing lines, serving similar pain management and behavioral health providers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gri-labs

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gri Labs